Anticoagulant Therapy in Thrombosis and Embolism

REFERENCES

• McLean, Jay: The thromboplastic action of cephalin. Am. J. Physiol., 41:250, 1916.
   Google Scholar
• Charles, A. F., and Scott, D. A.: Studies on heparin. IV. Observations on the chemistry of heparin. Biochem. J., 30: 1927, 1936.
   PubMedGoogle Scholar
• Chargaff, Erwin, Ziff, Morris, and Moore, D. H.: Studies on the chemistry of blood coagulation. XII. An electrophoretic study of the effect of anticoagulants on human plasma proteins, with remarks on the separation of the heparin complement. J. Biol. Chem., 139:383, 1941.
   Google Scholar
• de Takats, Geza: Heparin tolerance; a test of the clotting mechanism. Surg., Gynec. and Obst., 77:31. 1943.
   Google Scholar
• Murray, D. W. G., and Best, C. H.: Heparin and thrombosis; the present situation. J.A.M.A., 110:118; 1938.
   Google Scholar
• Priestley, J. T., and Barker, N. W.: Postoperative thrombosis and embolism; their treatment with heparin. Surg., Gynec. and Obst. 75:193, 1942.
   Google Scholar
• Crafoord, Clarence, and Jorpes, Erik: Heparin as a prophylactic against thrombosis. J.A.M.A., 116:2831, 1941.
   Google Scholar
• Loewe, Leo, Rosenblatt, Philip, and Hirsch, Edward: Venous thromboembolic disease. J.A.M.A., 130:386, 1946.
   PubMed Web of Science ®Google Scholar
• Murray, G. D. W., and Best, C. H.: Use of heparin in thrombosis. Ann. Surg., 108:163, 1938.
   PubMedGoogle Scholar
• Murray, Gordon: Heparin in surgical treatment of blood vessels. Arch. Surg., 40:307, 1940.
   Google Scholar
• McClure, R. D., and Lam, C. R.: Experiences in heparin administration. J.A.M.A., 114:2085, 1940.
   Google Scholar
• Bauer, Gunnar: Thrombosis; early diagnosis and abortive treatment with heparin. Lancet, 1:447, 1946.
   PubMedGoogle Scholar
• Campbell, H. A., and Link, K. P.: Studies on the hemorrhagic sweet clover disease. IV. The isolation and crystallization of the hemorrhagic agent. J. Biol. Chem., 138:21, 1941.
   Google Scholar
• Stahmann, M. A., Huebner, C. F., and Link, K. P.: Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent. J. Biol. Chem., 138: 513. 1941
   Google Scholar
• Allen, E. V., Barker, N. W., and Waugh, J. M.: A preparation from spoiled sweet clover [3, 3′-methylene-bis-(4-hy- droxycoumarin)] which prolongs coagulation and prothrombin time of the blood: a clinical study. J.A.M.A., 120:100–9, 1942.
   Google Scholar
• Spooner, Maryloo, and Meyer, O. O.: The influence of dicumarol on platelet adhesiveness. J. Lab. and Clin. Med., 30:390, 1945.
   Web of Science ®Google Scholar
• Wright, Helen P.: The adhesiveness of blood platelets in rabbits treated with dicoumarol. J. Path, and Exper. Bact., 57:382, 1945.
   Google Scholar
• Hum, Margaret, Barker, N. W., and Magath, T. B.: The determination of prothrombin time following the administration of dicumarol, 3, 3′-methylene-bis-(4-hydroxycoumarin), with special reference to thromboplastin. J. Lab. and Ciin. Med., 30:432, 1945.
   Web of Science ®Google Scholar
• Barker, N. W., Cromer, H. E., Hurn, Margaret, and Waugh, J. M.: The use of dicumarol in the prevention of postoperative thrombosis and embolism with special reference to dosage and safe administration. Surgery, 17:207, 1945.
   Web of Science ®Google Scholar
• Long, Mary, Hurn, Margaret, and Barker, N. W.: Effect of heparin on the prothrombin time. Proc. Staff Meet., Mayo Clin., 21:225, 1946.
   PubMed Web of Science ®Google Scholar
• Bollman, J. L., and Preston, F. W.: The effects of experimental administration of dicoumarin; 3, 3′-methylene-bis-(4-hydroxycoumarin). J.A.M.A., 120:1021, 1942.
   Google Scholar
• Dale, D. U., and Jaques, L. B.: The prevention of experimental thrombosis by dicoumarin. Canad. M.A.J., 46:546, 1942.
   PubMedGoogle Scholar
• Richards, R. K., and Cortell, Ruth: Studies on the anticoagulant 3, 3′-methylene-bis-(4-hydroxycoumarin). Proc. Soc. Exper. Biol, and Med., 50:237, 1942.
   Google Scholar
• Barker, N. W.: Anticoagulant therapy in postoperative thrombophlebitis and pulmonary embolism. Minnesota Med. 29: 778, 1946.
   PubMedGoogle Scholar
• Barker, N. W., Nygaard, K. K., Walters, Waltman, and Priesdey, J. T.: A statistical study of postoperative venous thrombosis and pulmonary embolism. III. Time of occurrence during the postoperative period. Proc. Staff Meet., Mayo Clin., 16:17, 1941.
   Google Scholar
• Barker, N. W., Nygaard, K. K., Walters, Waltman, and Priestley, J. T.: A statistical study of postoperative venous thrombosis and pulmonary embolism. I. Incidence in various types of operations. Proc. Staff Meet., Mayo Clin., 15:769, 1940.
   Google Scholar
• Nay, R. M., and Barnes, A. R.: Incidence of embolic or thrombotic processes during the immediate convalescence from acute myocardial infarction. Am. Heart J., 30:65, 1945.
   Web of Science ®Google Scholar
• Nichol, E. S., and Page, S. W., Jr.: Dicumarol therapy in acute coronary thrombosis; results in fifty attacks; with review of data on embolic complications and immediate mortality in myocardial infarction. J. Florida M. A., 32:365, 1946.
   PubMedGoogle Scholar
• Peters, H. R., Guyther, J. R., and Brambel, C. E.: Dicumarol in acute coronary thrombosis. J.A.M.A., 130:398, 1946.
   PubMed Web of Science ®Google Scholar
• Wright, I. S.: Experiences with dicumarol (3, 3′-methylenebis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction. Am. Heart J. 32:20, 1946.
   PubMed Web of Science ®Google Scholar
• Barker, N. W., Hines, E. A., Jr., and Kvale, W. F.: The treatment of acute arterial occlusion of the extremities with special reference to anticoagulant therapy. Minnesota Med., 29:250; 280, 1946.
   PubMedGoogle Scholar